Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Liposome Preemptive Analgesia for Postoperative Pain and Delirium in Elderly Hip Fracture Patients
NCT07066111Phase 4Not yet recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Nanjing First Hospital. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07066111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07066111.